Gilead Sciences
GILD
1,576 hedge funds and large institutions have $73.2B invested in Gilead Sciences in 2017 Q4 according to their latest regulatory filings, with 202 funds opening new positions, 535 increasing their positions, 692 reducing their positions, and 116 closing their positions.
74% more first-time investments, than exits
New positions opened: 202 | Existing positions closed: 116
5% more funds holding
Funds holding: 1,505 → 1,576 (+71)
1.25% more ownership
Funds ownership: 77.03% → 78.27% (+1.2%)
10% less capital invested
Capital invested by funds: $81.5B → $73.2B (-$8.29B)
23% less repeat investments, than reductions
Existing positions increased: 535 | Existing positions reduced: 692
40% less call options, than puts
Call options by funds: $1.58B | Put options by funds: $2.64B
46% less funds holding in top 10
Funds holding in top 10: 97 → 52 (-45)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$794M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$529M |
| 3 |
Dodge & Cox
San Francisco,
California
|
+$418M |
| 4 |
Sanders Capital
West Palm Beach,
Florida
|
+$382M |
| 5 |
CGI
CI Global Investments
Oakland,
California
|
+$275M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$300M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$273M |
| 3 |
Renaissance Technologies
New York
|
-$202M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$201M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$194M |
GILD Hedge Fund Activity: Q4 2017 in Review
1,576 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2017, worth a combined $73.2B — down 10% from $81.5B a quarter earlier.
Buyers outnumbered sellers: 202 funds opened new GILD positions and 116 closed out — a net gain of 86 holders — while 535 added to existing stakes and 692 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $794M. The largest seller was C WorldWide Group, cutting an estimated $300M.
- 1,576 institutional investors held Gilead Sciences (GILD) as of Q4 2017, up from 1,505 in Q3 2017.
- Funds reported $73.2B of Gilead Sciences stock for Q4 2017, down 10% quarter-over-quarter.
- 202 funds opened new Gilead Sciences positions in Q4 2017 and 116 closed out, a net change of +86 holders.
- The largest Gilead Sciences buyer in Q4 2017 was Capital Research Global Investors, an estimated $794M added.
- The largest Gilead Sciences seller in Q4 2017 was C WorldWide Group, an estimated $300M sold.
Based on aggregated 13F filings for Q4 2017.